OpenAI Launches GPT-Rosalind for Biology and Drug Discovery
OpenAI has introduced GPT-Rosalind, a specialized AI model for life sciences research. The system aims to accelerate drug discovery and biological analysis workflows.
Comprehensive coverage of academic breakthroughs, patents, labs and experimental models pushing the frontiers of technology. Discover how cutting-edge research turns into practical innovation across industries and influences the next generation of products. This category captures the pipeline from idea to market.
OpenAI has introduced GPT-Rosalind, a specialized AI model for life sciences research. The system aims to accelerate drug discovery and biological analysis workflows.
Researchers at NTU Singapore have developed an AI-powered biochip that detects disease-linked microRNAs in minutes. The system could enable faster, more precise diagnostics.
AWS has launched Amazon Bio Discovery, an AI-powered platform that helps scientists design, test, and refine drugs faster using integrated models and lab workflows.
Novo Nordisk is teaming up with OpenAI to use AI in drug discovery and development, aiming to speed up treatments for obesity and diabetes.
New research shows that telling AI models they are “experts” can reduce accuracy in tasks like coding and math, while improving safety and alignment outcomes.
A Sydney engineer used AI tools including ChatGPT and AlphaFold to help design a personalized mRNA cancer vaccine for his dog with help from university researchers....
Anthropic has launched the Anthropic Institute to study the societal, economic, and governance challenges posed by advanced AI systems. The initiative will combine research from engineers,...
Researchers report that ChatGPT-5.2 Pro helped simplify and generalize a complex gluon scattering formula, with results presented at the AAAS annual meeting.
Google launched Gemini 3 Deep Think, a specialized reasoning mode designed for research and engineering challenges. The update is available to AI Ultra subscribers and select...
Anthropic is collaborating with Howard Hughes Medical Institute and the Allen Institute to apply its Claude AI model to accelerate biological research and scientific discovery.
Google DeepMind has introduced AlphaGenome, a new AI model designed to analyze long DNA sequences and predict how genetic variations may influence disease development.
Bristol Myers Squibb and Microsoft have launched a collaboration to accelerate early detection of lung cancer using AI-powered radiology tools, with a focus on underserved communities.